神经元特异性烯醇化酶与接受机械取栓患者临床结局之间的关系

The Relationship Between Neuron-Specific Enolase and Clinical Outcomes in Patients Undergoing Mechanical Thrombectomy

ES评分 0

DOI 10.2147/NDT.S400925
刊名
年,卷(期) 2023, 19(/)
作者
作者单位 Department of Neurology, Nanjing First Hospital, Nanjing Medical University;
Department of Critical Care Medicine, Nanjing First Hospital, Nanjing Medical University;
School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University

摘要
目的: 神经元特异性烯醇化酶(NSE)被认为是反映神经系统疾病严重程度的生物标志物。本研究旨在探讨接受机械取栓(MT)的缺血性卒中患者血清NSE浓度是否与3个月功能结局及症状性颅内出血(sICH)相关。 患者与方法: 我们回顾性收集了本卒中中心前循环梗死且在6小时内接受MT的急性缺血性卒中患者资料。3个月良好结局和不良结局分别定义为改良Rankin量表(mRS)评分0–2分和3–6分。sICH根据海德堡出血分类定义。我们采用多因素logistic回归模型和受试者工作特征曲线探讨NSE与临床结局的相关性。 结果: 共纳入426例患者,其中40例(9.4%)发生sICH。3个月良好结局160例(37.6%),不良结局266例(62.4%)。血清NSE水平与3个月mRS评分显著相关(R = 0.473,P < 0.001)。血清NSE区分3个月不良结局和sICH的截断值分别为15.29 ng/mL和23.12 ng/mL(曲线下面积分别为0.724和0.716)。多因素分析显示,高血清NSE水平与3个月不良结局(比值比[OR] 5.049,95%置信区间[CI] 2.933–8.689,P < 0.001)和sICH(OR 5.111,95% CI 2.210–11.820,P < 0.001)独立相关。 结论: 本研究表明,接受MT后高血清NSE水平与急性缺血性卒中患者3个月不良结局和sICH独立相关。血清NSE水平可能是接受MT患者临床结局的良好预测指标。
Abstract
Purpose: Neuron-specific enolase (NSE) is considered a biomarker for the severity of nervous system diseases. We sought to explore whether serum NSE concentration in ischemic stroke patients undergoing mechanical thrombectomy (MT) is related to 3-month functional outcome and symptomatic intracranial hemorrhage (sICH). Patients and Methods: We retrospectively collected the data of acute ischemic stroke patients with anterior circulation infarction receiving MT within 6 h in our stroke center. Favorable outcome and poor outcome at 3 months were defined as modified Rankin Scale (mRS) score 0–2 and 3–6, respectively. sICH was defined according to the Heidelberg bleeding classification. We used multivariate logistic regression model and receiver operating characteristic curves to investigate the correlation between NSE and clinical outcomes. Results: Among the 426 patients enrolled, 40 (9.4%) patients developed sICH. Three-month favorable outcome in 160 (37.6%) and poor outcome in 266 (62.4%) patients were observed. Serum NSE levels was significantly correlated with 3-month mRS score (R = 0.473, P < 0.001). A cutoff value of 15.29 and 23.12 ng/mL for serum NSE was detected in discriminating 3-month poor outcome (area under the curve, 0.724) and sICH (area under the curve, 0.716), respectively. Multivariate analysis showed that high serum NSE levels were independently associated with 3-month poor outcome (odds ratio [OR] 5.049, 95% confidence interval [CI] 2.933–8.689, P<0.001) and sICH (OR 5.111, 95% CI 2.210–11.820, P < 0.001). Conclusion: Our study demonstrated that high serum NSE levels after receiving MT were independently associated with 3-month poor outcome and sICH in acute ischemic stroke patients. Serum NSE levels could be a good predictor of clinical outcomes for patients receiving MT.
关键词
神经元特异性烯醇化酶;缺血性卒中;机械取栓;症状性颅内出血;预后。
KeyWord
neuron-specific enolase, ischemic stroke, mechanical thrombectomy, symptomatic intracranial hemorrhage, prognosis
基金项目
页码 709-719
  • 参考文献
  • 相关文献
  • 引用本文

QiangPeng,WenxiuChen,YanE,YangDeng,ZhaohanXu,SiyuWang,XinxinFu,BinWei,MengWang,JiankangHou,YingdongZhang,RuiDuan. 神经元特异性烯醇化酶与接受机械取栓患者临床结局之间的关系 [J]. Neuropsychiatric Disease and Treatment. 2023; 19; (/). 709 - 719.

  • 文献评论

相关学者

相关机构